This study is in progress, not accepting new patients
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients with GEP-NET
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Camurus AB
- ID
- NCT05050942
- Phase
- Phase 3 Neuroendocrine Tumor Research Study
- Study Type
- Interventional
- Participants
- About 332 people participating
- Last Updated